Keros Therapeutics is dedicated to developing innovative therapies targeting dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. The company focuses on shifting treatment paradigms for patients with various disorders, offering a distinctive approach by leveraging cutting-edge research and development in this area.
Keros is seeking a Director of Clinical Operations (DCO) to lead the execution of clinical trials, ensuring compliance, and maximizing program and corporate objectives. The role involves leading clinical trial teams, representing clinical operations at meetings, and contributing to process improvement. The DCO will be a primary point of escalation for trial management issues.
Keros Therapeutics is dedicated to developing innovative therapies targeting dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. The company focuses on shifting treatment paradigms for patients with various disorders, offering a distinctive approach by leveraging cutting-edge research and development in this area.
Dianthus Therapeutics, Inc.